XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues $ 20,591 $ 21,970 $ 62,815 $ 69,579
Cost of revenues 8,570 9,205 27,077 28,824
Gross profit 12,021 12,765 35,738 40,755
Sales and marketing expenses 4,613 5,518 14,123 16,817
General and administrative expenses 4,176 5,041 13,623 16,690
Research and development expenses 2,132 2,567 6,642 8,078
Amortization of acquired intangible assets 855 1,334 3,177 3,998
Goodwill impairment - Note 4 0 0 47,951 0
Other operating expenses - Note 1 48 179 512 1,394
Total operating expenses 11,824 14,639 86,028 46,977
Operating income (loss) 197 (1,874) (50,290) (6,222)
Nonoperating Income (Expense)        
Interest expense (966) (856) (2,559) (2,356)
Loss on pension settlement 0 (1,243) 0 (1,243)
Loss on equity securities - Note 6 0 0 0 (1,593)
Other expense, net (365) (518) (1,333) (841)
Total other expense (1,331) (2,617) (3,892) (6,033)
Loss before income taxes (1,134) (4,491) (54,182) (12,255)
Income tax expense (benefit) 97 311 (329) 168
Net loss $ (1,231) $ (4,802) $ (53,853) $ (12,423)
Loss per share:        
Basic and diluted loss per share (in dollars per share) $ (0.03) $ (0.11) $ (1.22) $ (0.29)
Weighted-average common shares:        
Basic and diluted (in shares) 44,556 43,614 44,320 43,499